FDA Says “Stands Ready” To Work With Companies Developing Ebola Drugs

free biotech news

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

The worst Ebola outbreak in history is heaping new pressure on U.S. regulators to speed the development of treatments for the deadly virus, which has killed more than 700 people since February. The U.S. Food and Drug Administration on Friday said in an emailed statement the agency “stands ready” to work with companies and investigators working with patients “in dire need of treatment.” A senior official within FDA told Reuters the agency would consider proposals for providing treatments under special emergency new drug applications, if the benefits of the treatment outweighed the potential safety risks.

Hey, check out all the research scientist jobs. Post your resume today!

MORE ON THIS TOPIC